{"id":"W2946555506","doi":"10.14785/lymphosign-2019-0005","title":"A clinical trial protocol to evaluate the safety and pharmacokinetics of subcutaneously administered immunoglobulin in patients with primary immunodeficiency","year":2019,"lang":"en","type":"article","venue":"LymphoSign Journal","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Primary immunodeficiency; Tolerability; Pharmacokinetics; Adverse effect; Clinical trial; Population; Protocol (science); Immunodeficiency; Clinical research; Antibody; Intensive care medicine; Pediatrics; Pharmacology; Immunology; Internal medicine; Pathology; Alternative medicine; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0235866,0.002909141,0.003531225,0.001147678,0.002554755,0.002088653,0.002017345,0.005474345,0.06902418],"category_scores_gemma":[0.02378107,0.001533741,0.002293255,0.001319875,0.001656252,0.00210263,0.001425614,0.006511351,0.01376557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002587033,"about_ca_system_score_gemma":0.01263959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000612291,"about_ca_topic_score_gemma":0.001917675,"domain_scores_codex":[0.98674,0.009085186,0.001684469,0.0007155572,0.001001294,0.0007736232],"domain_scores_gemma":[0.9839586,0.004850139,0.002694368,0.00293813,0.003219887,0.002338939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6163645,0.02911479,0.002305758,0.02199038,0.002045926,0.00109809,0.0007375575,0.003474126,0.009019954,0.0182403,0.10212,0.1934886],"study_design_scores_gemma":[0.5745535,0.08570006,0.007784721,0.009175893,0.0009814131,0.0007429252,0.000263639,0.003245954,0.003225243,0.007703357,0.3063873,0.0002360031],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.003953676,0.0008047804,0.004720401,0.0007912633,0.0005797113,0.9805285,0.002536685,0.0001750884,0.005909895],"genre_scores_gemma":[0.004866951,0.0004546729,0.004653646,0.0006813732,0.0001706206,0.98684,0.0007079685,0.000009378255,0.001615288],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.06902418,"threshold_uncertainty_score":0.2309089,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01282099823741209,"score_gpt":0.2914420075128057,"score_spread":0.2786210092753936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}